Hudson Bay Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,000
Closed -$30.7K 1140
2025
Q1
$30.7K Buy
+12,000
New +$30.7K ﹤0.01% 807